Drug Trial Radar · NCT07768124
Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer
Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jul 15, 2026
Primary completion
Oct 15, 2026
Study completion Oct 15, 2026
Sponsor
- Lead sponsor
- Xiu HuangAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 17, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This single-center, randomized, controlled study evaluates whether acupoint application added to standard 5-HT3 receptor antagonist anti-nausea medication improves control of chemotherapy-induced nausea and vomiting in adults with lung cancer receiving first-line platinum-based chemotherapy. Participants will be randomly assigned to receive either acupoint application plus a 5-HT3 receptor antagonist or the 5-HT3 receptor antagonist alone for one chemotherapy cycle. The study will compare complete control of delayed nausea and vomiting between the two groups.
Conditions
- Lung Cancer (Diagnosis)Chemotherapy-Induced Nausea and Vomiting
Interventions
5-HT3 receptor antagonist (e.g., ondansetron)Drug
Standard antiemetic prophylaxis for chemotherapy-induced nausea and vomiting.
Acupoint applicationOther
Herbal plaster applied to selected acupoints to alleviate chemotherapy-induced nausea and vomiting.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete response rate of delayed-phase CINV (24-120 h)Time frame: 24 to 120 hours after the first cycle of platinum-based chemotherapy (each cycle is 21-28 days)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Affiliated Yongchuan Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.